I have been going through some older Nanosonics announcements and noticed that until 2012, there was a lot of emphasis on leveraging the Trophon and Xonar platforms into other areas (scientific labs, bed decontamination, food processing etc). Since then the information provided on IP development and R&D have been more and more vague, however R&D spend remains high. Does anyone know if there has been a strategic decision to focus solely on ultrasound probes, or whether there is still development of other applications going on?
I have been going through some older Nanosonics announcements...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.10 |
Change
0.045(1.11%) |
Mkt cap ! $1.235B | |||
| Open | High | Low | Value | Volume |
| $4.05 | $4.11 | $4.02 | $988.1K | 243.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 4644 | $4.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.10 | 5012 | 18 |
View Market Depth
| Last trade - 12.12pm 16/09/2025 (20 minute delay) ? |
| NAN (ASX) Chart |